I thought I would revive this thread - if it ever had life
Been doing a bit of research on publication of medical papers and these are my thoughts:
A simple paper with no peer review published in a down and dirty online Journal = 6 - 7 weeks
Better quality journal + 2 - 4 weeks minimum
Peer review + 2 weeks for something simple + 2 or more if not so simple or suitable reviewer (the journals have panels) not immediately available.
Rewrite taking into consideration feedback + 2 - 3 weeks
Controversy + 2?
Editing for publication + 2 Weeks
Acceptance for publication to actual Publication + 2 weeks + 2 or more for better regarded journals (more submissions).
So if submitted on time end of Feb + 16 - 26 weeks
That makes publication due from 24 May to 9th August is within normal scope.
Assuming it will be peer reviewed, in a better class of journal, not too much controversy, the reviewer didn't come down with covid etc
I reckon 7 + 3 + 4 + 2 + 2 +2 = 20 weeks which makes it due middle of July. The company said May but it is not in their control.
So really anytime in the next 4 weeks is my best estimation.
- Forums
- ASX - By Stock
- IPD
- PREVENT Trial
PREVENT Trial, page-5
-
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
|
|||||
Last
6.9¢ |
Change
-0.004(5.48%) |
Mkt cap ! $143.6M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 6.9¢ | $80.40K | 1.142M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 466408 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 56613 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 544990 | 0.069 |
2 | 147058 | 0.068 |
3 | 521359 | 0.067 |
4 | 191358 | 0.066 |
7 | 1207220 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 99434 | 7 |
0.072 | 20000 | 1 |
0.073 | 140257 | 3 |
0.074 | 321150 | 1 |
0.078 | 100000 | 1 |
Last trade - 14.18pm 03/07/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online